Target intelligence / Profile preview

Dengue virus serotype 2 envelope protein (DENV-2 E protein)

Target
DENV-2 E protein
Molecular classification
Viral envelope glycoprotein, Structural protein
01

Overview

The Dengue virus serotype 2 envelope protein (E protein) is the major surface glycoprotein on the mature virion, composed of 180 copies arranged as homodimers. It consists of three β-sheet domains (DI central, DII dimerization with fusion loop, DIII), a membrane-proximal stem, amphipathic helix, and transmembrane anchor. At neutral pH, it forms stable prefusion dimers; low pH in endosomes triggers rearrangement to postfusion trimers, driving viral-endosomal membrane fusion for genome release. It contains a hydrophobic ligand-binding pocket at the DI/DII interface that opens via β-hairpin shift, influencing fusion pH threshold. The protein exhibits temperature-dependent morphology (smooth at 29°C, bumpy at 37°C due to loosened dimer interactions) and is targeted by neutralizing antibodies at inter-dimer, intra-dimer, and domain-specific epitopes.

Other names
DENV2 envelope glycoproteinDENV-2 E glycoproteinsE protein (soluble ectodomain)
02

Mechanism of action

Neutralization by binding quaternary epitopes across E dimers to prevent conformational reorganization and membrane fusion, Binding domain III or fusion loop to disrupt virion architecture and induce premature fusion loop exposure

03

Biological functions

Mediates viral attachment and entry into host cellsUndergoes pH-induced conformational change from dimer to trimer for membrane fusionVirus budding by binding cell membrane and gathering viral RNA into nucleocapsid
04

Disease associations

Infection
05

Safety considerations

Antibody-dependent enhancement (ADE) in heterotypic infections due to serotype cross-reactivity
06

Interacting drugs

Monoclonal antibodies (e.g., 2D22

8 more in the full profile.

Beyond the preview

Go deeper on Dengue virus serotype 2 envelope protein (DENV-2 E protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dengue virus serotype 2 envelope protein (DENV-2 E protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call